FindTrial
Sign In

A clinical trial to study the effects of 2 doses of Magnesium sulphate in patients undergoing awake fiberoptic laryngoscopy

A comparative study between two doses of magnesium sulphate as sedative during awake fiberoptic intubation for patients undergoing maxillofacial surgeries: a randomized controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017716
Enrollment
80
Registered
2019-02-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S024- Fracture of malar, maxillary and zygoma bones Health Condition 2: S026- Fracture of mandible

Interventions

Intervention1: Magnesium Sulphate 30mg/kg: To administer 30 mg/kg Magnesium sulphate over 15 minutes, 20 minutes before attempting awake fiberoptic laryngoscopy Control Intervention1: Magnesium sulpha

Sponsors

IMS BHU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA Grade I and II

Exclusion criteria

Exclusion criteria: ASA Grade III and IV Allergy/Hypersensitivity to magnesium sulphate Cardiac arrhythmia/CHD/Cardiopulmonary disease Presence of cervical spine

Design outcomes

Primary

MeasureTime frame
Change in Ramsay Sedation ScoreTimepoint: During awake fiberoptic laryngoscopy—

Secondary

MeasureTime frame
Changes in blood pressure and heart rateTimepoint: During awake fiberoptic laryngoscopy—

Countries

India

Contacts

Public ContactArmaanjeet Singh

Institute of Medical Sciences, Banaras Hindu University

kvtamn68@gmail.com9711897587

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026